Macrophages are key players of immunity that display different functions according to their activation states. In a regenerative context, pro-inflammatory macrophages (Ly6C pos ) are involved in the mounting of the inflammatory response whereas anti-inflammatory macrophages (Ly6C neg ) dampen the inflammation and promote tissue repair. Reactive oxygen species (ROS) production is a hallmark of tissue injury and of subsequent inflammation as described in a bacterial challenge context. However, whether macrophages produce ROS following a sterile tissue injury is uncertain. In this study, we used complementary in vitro, ex vivo and in vivo experiments in mouse to show that macrophages do not release ROS following a sterile injury in skeletal muscle. Furthermore, expression profiles of genes involved in the response to oxidative stress in Ly6C pos and Ly6C neg macrophage subsets did not indicate any antioxidant response in this context. Finally, in vivo, pharmacological antioxidant supplementation with N-Acetyl-cysteine (NAC) following skeletal muscle injury did not alter macrophage phenotype during skeletal muscle regeneration. Overall, these results indicate that following a sterile injury, macrophage-derived ROS release is not involved in the regulation of the inflammatory response in the regenerating skeletal muscle.
Introduction
Macrophages play various important roles in tissue homeostasis [5] . They exhibit a wide spectrum of phenotypes or inflammatory status, which are associated with a diversity of functions [5] . Upon an immune challenge, macrophages invading the infected area exhibit a pro-inflammatory phenotype, that support microbicidal activity, mainly through the activation of Toll-like receptors (TLRs) upon recognition of Pathogen Associated Molecular Patterns (PAMPs). Once the pathogens phagocytozed and inactivated, resolution of inflammation takes place to avoid too much tissue degradation [5] . Inflammation is often associated with an increase of the production of reactive oxygen species (ROS) [11] . It is largely accepted that macrophages produce and release ROS to support bactericidal activity and counteract with invader pathogens [26] . Thus, ROS are important mediators of macrophage functions during immune challenges [4, 7] .
After a tissue damage that does not involve bacteria or virus (i.e. sterile inflammation), the activation of macrophages infiltrating the injured area was evidenced via the Damage Associated Molecular Patterns (DAMPs) that also activate TLRs. However, the extent and quality of the pro-inflammatory status of these pro-inflammatory macrophages have been poorly addressed in vivo. In this context, we recently showed that soon after skeletal muscle injury, monocyte-derived macrophages exhibit a pro-inflammatory status, which is different from that of classical M1 (IFNγ driven) activation and is likely related to tissue damage [22] . Few days after the injury, the resolution of inflammation takes place and macrophages switch their phenotype towards an anti-inflammatory/recovery status to exert repairing function in the tissue [14, 18, 2, 21] .
Whether pro-oxidant characteristics of macrophages that were described in the context of immune challenge does occur in the context of sterile inflammation is still uncertain. iNOS, which participates in the formation of Reactive Nitrogen Species (RNS) and ROS, is expressed by inflammatory macrophages during the first days of muscle regeneration, then its expression declines with time, notably when macrophages acquire the recovery inflammatory status [14] . Mice deficient for inos fail to regenerate correctly because of a defect of myogenesis [19] suggesting, because inos is mainly expressed by inflammatory macrophages infiltrating the injured area, that macrophage-derived iNOS plays a role in skeletal muscle regeneration. However, despite the assumption that inflammatory macrophages generally produce ROS that are detrimental for the tissue, no study has characterized macrophage ROS production in the context of skeletal muscle regeneration or tissue repair.
The aim of the present study was to evaluate the production of ROS by macrophage populations during skeletal muscle regeneration. To address this question, we combined in vitro and ex vivo approaches of direct biochemical measurements of ROS entities, ex vivo analysis of the "oxidative" gene profile of macrophages isolated from regenerating muscle, and in vivo pharmacological antioxidant supplementation during skeletal muscle regeneration.
Materials and methods

Macrophage culture
Macrophages were obtained from bone marrow (BM) precursor cells as previously described [14] . Briefly, total BM was cultured in DMEM (Gibco) containing 20% fetal bovine serum (FBS) and 30% conditioned medium of L929 cell line. Macrophages were seeded (200,000 cells/ cm 2 ) and activated in DMEM medium containing 10% FBS for 3 days as follows: IFNγ (50 ng/ml), IL-4 (10 ng/ml), IL-10 (10 ng/ml), Muscle Damage Associated Molecular Patterns (DAMPS) (homogenate from a muscle injured by ischemia/reperfusion, 1 μg/ml), lipopolysaccharide (LPS, 10 ng/ml) and Phorbol 12-myristate 13 acetate (PMA, 50 ng/ml). After several washes, conditioned medium was obtained after 24 h of culture of activated macrophages in DMEM serum-free medium.
Superoxide ion production assessment
Superoxide ion production assessment procedure was previously fully detailed [3] . Ferricytochrome c reduction was used to assess the superoxide ion production by macrophages. Macrophages activated as described above were incubated at 37°C for 2 h with 1 ml of HEPES buffer (53 mM HEPES) pH 7.4 containing 14.6 mM glucose, 358 mM NaCl, 12.7 mM KCl, 3.1 mM KH 2 PO 4 , 6.1 mM MgSO 4 , 3.1 mM CaCl 2 , 13 mM NaHCO 3 , 0.4 mM EDTA and 100 µM ferricytochrome. Absorbance was read at 550 nm with a spectrophotometer (BioSpectrometer Basic Eppendorf). Contribution of ferricytochrome c at 100 μM (absorbance at 800 nm) was substracted. Similar measurements were realized on macrophages isolated by FACs (see below) and subsequently plated for 2 h in the absence or presence of PMA (50 ng/ml) to induce an oxidative burst [1] .
Superoxide dismutase expression
Protein concentration was determined in macrophage lysates using BCA protein assay (Uptima-Interchim). Western blot analysis was performed to examine the expression of MnSOD (rabbit polyclonal antihuman SOD2 200 µg/ml, Santa Cruz Biotechnology) and Cu-ZnSOD (rabbit polyclonal anti-human SOD1 200 µg/ml, Santa Cruz Biotechnology) versus that of actin (Goat polyclonal anti-human actin 200 µg/ml, Santa Cruz Biotechnology). Quantification of the band intensity was performed using ImageJ Software.
Macrophage H 2 O 2 release
Extracellular H 2 O 2 was detected using the Amplex Red hydrogen peroxide/peroxidase assay kit (Invitrogen). Macrophage-conditioned medium was collected and incubated with the Amplex Red reagent (50 μl of 10 mM solution) and horseradish peroxidase (100 μl of 10 U/ ml solution) in 0.25 M sodium phosphate buffer for 30 min. Absorbance intensity was measured on an Apollo LB 911 plate reader (Berthold Technologies) at 560 nm.
Skeletal muscle injury
Eight week-old C57/Bl6 and CX3CR1 GFP/+ male mice were used for N-acetylcysteine (NAC, Sigma) supplementation protocol and extraction of macrophages from regenerating muscle, respectively. Mice were bred and used in compliance with French and European regulations. Principal investigators are licensed for animal experimentation and the ethical committee validated the protocol. Muscle injury was caused by injection of cardiotoxin (CTX) in the Tibialis Anterior muscle as previously described [14] . In some experiments, LPS (50 μg/ml final) was co-injected with CTX as previously described [22] . In some experiments, NAC was administered at 4% in drinking water for 8 days from the day of injury, as previously described [20] .
Isolation of immune cells from regenerating muscle
Immune cells were isolated as described previously [14, 22] . Briefly, muscles were minced and digested with collagenase B 0.2%. CD45 + cells were isolated by magnetic sorting procedure (Miltenyi Biotec) and further labeled with APC-CD64 and PE-Ly6C antibodies for C57/Bl6 mice and with an APC-Ly6C (all from eBiosciences) antibody for CX3CR1 GFP/+ mice. Cells were sorted using a FACS Aria II cell sorter (BD Biosciences).
Histological analysis
At different time-points after injury (day 4, 8 and 28) regenerating muscles were harvested, snap-frozen in nitrogen-chilled isopentane and kept at −80°C until analysis. 10 μm-thick muscle cryosections were prepared and used for H/E staining and immunofluorescent staining. Cryosections were treated with antibodies directed against F4/80 (#ab6640, Abcam), iNOS (#ab15323, Abcam), and CD206 (#sc-58987, Santa Cruz) revealed with FITC-or Cy3-conjugated antibodies (Jackson Immunoresearch Inc). Pictures were recorded with Axioscop microscope (Zeiss) at 20× of magnification connected to AxioCam ICc5 (Zeiss). For each condition in each experiment, at least 8-10 randomly chosen fields were counted. The number of labeled macrophages was calculated using ImageJ software and was expressed as a percentage of total macrophages.
For Cross Section Area (CSA) analysis, cryosections were labeled with antibodies directed against Laminin (#L9393, Sigma-Aldrich) and revealed with FITC-conjugated secondary antibody. Pictures covering the whole cryosection were recorded with an Axio Observer.Z1 (Zeiss) at 10× of magnification connected to a CoolSNAP HQ2 CCD Camera (Photometrics). CSA was determined manually using ImageJ software. A mean of 2345 ± 542 fibers were analyzed per TA muscle.
For satellite cells analysis, fresh cryosections were labeled with antibodies directed against Pax7 (clone 4ea, DHSB) and Laminin (#L9393, Sigma-Aldrich) revealed with Cy3-and FITC-conjugated antibodies, respectively. Pictures were recorded with an Axio Imager.Z1 (Zeiss) at 20× of magnification connected to a CoolSNAP Myo CCD Camera (Photometrics). For each condition, 10 randomly chosen fields were counted. The number of satellite cells was determined manually using ImageJ software and expressed as the number of Pax7+ cells per 100 fibers.
Statistical analyses
Results are expressed as means ± SEM. All experiments were carried out with at least 3 different primary cultures or 3 mice for in vivo analyses. Isolation of macrophages from regenerating muscle required 3-5 mice that were pooled. Mann-Whitney and Kruskal-Wallis tests were done with Prism software.
Results
Pro-and anti-inflammatory macrophages release similar levels of ROS in vitro
To investigate ROS production by differentially activated macrophages, BM-derived macrophages were treated with IFNγ, with IL-4 or with IL-10 to trigger pro-inflammatory, alternative and anti-inflammatory activation, respectively [16] . Superoxide production in conditioned medium was assessed using ferricytochrome c reduction assay [3] . This method, based on the reduction of cytochrome c by superoxide to form detectable ferrocytochrome, reflects the extracellular production of superoxide. No significative superoxide production was observed upon the 3 treatments, despite a slight increase by macrophages activated with IFNγ (Fig. 1A) . To investigate ROS production by pro-inflammatory macrophages in vitro, cells were treated with various effectors known to induce pro-inflammatory states including a ROS-inducer (PMA), a bacterial mimetic (LPS) and a lysate from injured skeletal muscle (DAMPS). Because the measurement of anion superoxide release has never been performed in these conditions, we added two positive controls known as superoxide generators: a strong chemical inducer (PMA) [17] and LPS. LPS activates superoxide production and hydrogen peroxide-derived superoxide. We also tested DAMPS as a putative superoxide activator. Hence, we validated our measurement setup and were able to underline the differences between classical models of activation based on cytokine treatment and the above-mentioned treatments. Among the 3 treatments, only PMA (+139 ± 9%) (p < 0.05) treatment induced superoxide detection as compared with untreated macrophages (NT) (Fig. 1A) . To further explore ROS metabolism in activated macrophages, the level of H 2 O 2 , which is the product of superoxide dismutation by superoxide dismutases (SODs) [8] , was measured in conditioned media. Surprisingly, hydrogen peroxide production was similar in all macrophage populations (Fig. 1B) . The important lability of H 2 O 2 can explain these results. Overall, these data indicate that macrophages released similar levels of superoxide and H 2 O 2 irrespective of their activation state.
We further examined the expression of superoxide dismutase (SOD) enzymes by activated macrophages. MnSOD (or SOD2) is a mitochondrial enzyme responsible of the dismutation of primary formed superoxide into hydrogen peroxide, the most common reaction of ROS metabolism cascade [8] . MnSOD expression was higher in IFNγ macrophages as compared with (IL-10) macrophages (p < 0.05) (Fig. 1C) . Additionally, cytosolic SOD1 (or CuZn-SOD) expression was not significantly different in the various activated macrophages (Fig. 1D) . These data indicate that mitochondrial SOD2 was overexpressed only in pro-inflammatory macrophages, leading to an improvement of the dismutation capacity of pro-inflammatory macrophages that may result in a similar ROS release as compared with other activated macrophages.
Macrophages produce low levels of superoxide during post-injury skeletal muscle regeneration in vivo
To investigate ROS production by macrophages during muscle regeneration, macrophages subsets and neutrophils were sorted from regenerating muscle at day 2 after injury and assayed for the evaluation of superoxide production ( Fig. 2A) . At day 2, both LyC6 pos and Ly6C neg populations are equally present [14, 21] . No significant superoxide production was detected in both Ly6C pos and Ly6C neg macrophage subsets and neutrophils, as compared with the control solution ( Fig. 2A,  right panel) . To test the experimental conditions and the ability of myeloid cells isolated from regenerating muscles to produce superoxide, sorted macrophages and neutrophils were immediately treated with PMA, which induces an oxidative burst and is widely used to study ROS production in myeloid cells. In this condition, PMA-stimulated neutrophils significantly produced ROS, with an upregulation of superoxide release of 162.6 ± 9.4% (p < 0.001) ( Fig. 2A, right panel) . Additionally, a skeletal muscle injury model with concomitant bacterial contamination with LPS was used to induce a stronger proinflammatory profile of Ly6C pos macrophages [22] (Fig. 2B, left panel) .
No significant superoxide production was detected in both macrophage subsets and neutrophils, as compared with the control solution (Fig. 2B,  right panel) . Again, treatment with PMA stimulated only neutrophils to produce superoxide (144.1 ± 13.2%, p < 0.05) (Fig. 2B, right panel) . Taken together, these results indicate that after an injury, macrophages invading skeletal muscle release, if any, very low levels of superoxide.
Gene expression profiling does not reveal antioxidant-related response in macrophages after skeletal muscle injury
The oxidative stress signature of macrophages present in regenerating muscles was investigated, using a microarray analysis published in [22] . As expected, Ly6C pos macrophages expressed higher levels of a series of genes known to be associated with pro-inflammatory macrophages in skeletal muscle regeneration, including selectin L, CSF1, IL6 and CCR1 (Fig. 3, upper panel) . A set of antioxidant genes that would identify an antioxidant-related transcriptional signature was analyzed in both macrophage subsets. There was no significant differential expression of 30 genes associated with response to oxidative stress between inflammatory Ly6C pos and restorative Ly6C neg macrophage subsets (Fig. 3, lower panel) .
NAC treatment impairs skeletal muscle regeneration after injury
To further assess a potential functional role of ROS in macrophages during skeletal muscle regeneration, we used a pharmacological approach using antioxidant NAC oral treatment, given from the time of muscle injury. Indeed, NAC should counteract the ROS released at early time points by pro-inflammatory macrophages. Inversely, if no ROS are present in the injured muscle, NAC should not affect skeletal muscle regeneration.
First, macrophage inflammatory status was investigated by performing double immunofluorescent staining for F4/80 and iNOS or CD206, to identify pro-and anti-inflammatory macrophages, respectively [14] . At day 4 after injury, there was no difference in the percentage of macrophages expressing iNOS or CD206 between control and NAC-treated muscles (Fig. 4A) . The number of necrotic and phagocyted myofibers was calculated 8 days after injury, a time point when most of necrosis and phagocytosis of injured myofibers is over [14] . Although exhibiting high variations between individuals, NAC-treated group did not significantly differ from the control group (Fig. 4B) , indicating no significant difference in the time course of the regeneration process. Four weeks after injury, NAC treatment was associated with a reduction of body weight (−9%, p < 0.01), Tibialis Anterior muscle mass (−15%, p < 0.001) and Tibialis Anterior mass/body mass ratio (−8%, p < 0.05) (Fig. 5B) . This was correlated with a decrease in mean Cross Section Area (−15%, p < 0.05) and a shift of the myofiber size towards the smaller ones (Fig. 5C) . Additionally, muscles from NAC-treated group displayed a significant lower number of nuclei per fiber as compared with the control group (−22%, p < 0.001) (Fig. 5D) . Finally, NAC-treated muscles did not show a significant difference in the number of satellite cells (Fig. 5E) . Altogether, these results suggest that NAC treatment primarily affected myofiber growth than early events related to inflammation during skeletal muscle regeneration. 
Discussion
We investigated ROS release from macrophages during regenerating skeletal muscle and provided evidence that after a sterile injury, infiltrated macrophages did not release ROS and that antioxidant supplementation impaired long term skeletal muscle regeneration. To our knowledge, only one study investigated whole skeletal muscle redox changes following skeletal muscle injury induced by venom injection. It was described that skeletal muscle injury is accompanied by an increase of ROS production within the whole tissue from 1 to 7 days after injury [23] . However, the pro/antioxidant-related measurements were not specific to macrophage populations. These results, combined to those of the present study, suggest that ROS present in the early injured muscle are mainly derived from the myofiber than from the inflammatory compartment.
ROS are short lived and direct detection is difficult, notably in vivo, despite recent technological advances [15, 27] . Here, we used biochemical assays such as ferricytochrome c reduction and Amplex Red technology, which are robust, specific and adequate methods to detect the major ROS that are superoxide and hydrogen peroxide produced by the cells and released in their microenvironment [25, 3] .
We report that among a set of in vitro activation, only macrophages treated with PMA, which induces the oxidative burst in macrophages [1] , present a significant ROS production. Additionally, no difference was observed in the release of H 2 O 2 , which is the product of superoxide dismutation, between the different activated macrophage populations. Protein expression of MnSOD, responsible of the dismutation of superoxide into hydrogen peroxide, the most common reaction of ROS metabolism cascade at this step [8] , is higher in IFNγ treated macrophages as compared with other activated macrophages. This distinct pattern of MnSOD is a hallmark of IFNγ-activated macrophages [10] . This result indicates that a higher MnSOD protein expression may counteract a higher production of superoxide (not detectable in our experimental conditions) as a stress response to restore cellular homeostasis.
Ex vivo isolation of pure populations of pro-inflammatory and antiinflammatory macrophages (Ly6C pos and Ly6C neg , respectively) two days after muscle injury revealed no significant superoxide release by these cells. Technically, sorted cells, here neutrophils, were shown to secrete superoxide after PMA treatment. Similar results were observed after muscle injury upon LPS co-injection, that induces a stronger proinflammatory profile in Ly6C pos macrophages [22] . ROS production is an important feature of macrophages, notably following activation with pathogens [26, 6, 9] , that constitutes a different context from sterile tissue injury. The absence of a high oxidative response in macrophages upon muscle injury, notably in Ly6C pos macrophages at early time points after injury, was confirmed by gene expression analysis. The mRNA expression of about 30 genes related to oxidative stress did not differ between inflammatory Ly6C pos and restorative/Ly6C neg macrophage from injured muscle. More broadly, gene profiling analysis of these two populations indicated that following a sterile muscle injury, inflammatory Ly6C pos macrophages exhibit a specific inflammatory profile which is different from the classical M1 (IFNγ driven) status and which is strongly different from that of pathogen-challenged macrophages [22] . Finally, our in vivo pharmacological approach aimed at targeting ROS production early after injury, with the antioxidant NAC, a molecule commonly used as therapeutics in a large number of pathophysiological contexts including skeletal muscle diseases and in exercise and sport performance context [11, 13] . We showed that NAC treatment did not alter macrophage phenotype at early time points after injury, in accordance with the above results indicating the absence or ROS release from macrophages in this context. While the number of necrotic myofibers was not significantly different from that observed in the control muscle, NAC-treated muscles showed a highly heteregenous, somewhat increased level of necrosis 8 days after the injury, deserving further investigation on the phagocytic capacities of macrophages in these conditions. Finally, parameters of myofiber growth and fusion were altered in NAC-treated muscle 28 days after injury, suggesting an impact of antioxidant treatment on ROS-unrelated properties of restorative macrophages or directly on the myogenesis process. However, the number of satellite cells was unchanged after NAC treatment, suggestive of an impact of NAC on the late stage of myogenesis, that deserves further exploration. Indeed, several pathways involved in myogenesis processes may be regulated by oxidative stress, for instance IGF-I signaling or Akt-mTOR pathways [11] . This is also suggested by a study showing that NAC supplementation after an exercise-induced muscle damage (EIMD) in human blunts the circulating inflammatory response (assessed by indirect measurements in blood) and decreases the EIMD-induced increase in the phosphorylation of a series or proteins involved in myofiber growth (PKB, mTOR, p70S6K, S6, MAPK P38). Consequently, performance of the NAC-treated group was decreased [13] .
Our results appear to be in sharp contrast with what is observed Necrotic/phagocytosed fibers were counted on muscle sections stained with H/E at day 8 after injury. Results are mean ± SEM of a minimum 3 mice. during muscular dystrophies. Indeed, the increase in oxidative stress in muscular dystrophies is a well-known process and correlates with the severity of the pathology [11] . Accordingly, antioxidant treatments ameliorate the morphological, biochemical, and functional phenotype of the diseased muscle, including a decrease in inflammatory cells [11] . However, the redox status of inflammatory cells, including macrophages, has not been addressed in this pathological context yet. Nevertheless, as the inflammatory status of macrophages is different during skeletal muscle regeneration and during dystrophies [12, 24] , it is likely that their redox status will also differ significantly between acute and chronic injuries.
In conclusion, this study indicates that, contrary to an immune challenge implicating bacteria or virus, macrophage-derived ROS release is absent or weak after a sterile tissue damage, and does not impact the skeletal muscle regeneration process. Additionally, we report that antioxidant supplementation from the time of injury does not impact macrophage inflammatory status but may conversely be deleterious in the later restorative phase of skeletal muscle regeneration.
